Overview

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to assess the safety and tolerability of BMS-641988 once daily orally in Japanese patients with castration resistant prostate cancer
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb